Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 5 |
| List of Tables | 4 | 2 |
| List of Figures | 6 | 1 |
| University College London, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 6 | 2 |
| University College London, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 8 | 1 |
| University College London, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 9 | 1 |
| University College London, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 10 | 2 |
| University College London, Medical Devices Deals, 2010 to YTD 2016 | 12 | 1 |
| University College London, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 13 | 4 |
| University College London, Pharmaceuticals &Healthcare, Deal Details | 17 | 49 |
| Venture Financing | 17 | 1 |
| Orchard Therapeutics Raises USD31 Million in Series A Venture Financing | 17 | 1 |
| Puridify Raises USD3.4 Million in Series A Financing | 18 | 1 |
| Puridify Raises USD1.43 Million in Seed Funding | 19 | 1 |
| Canbex Therapeutics Raises US$3 Million In Venture Financing | 20 | 2 |
| Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round | 22 | 2 |
| UCL Business Raises US$71 Million In First Round Financing | 24 | 1 |
| Partnerships | 25 | 1 |
| Cell Medica Enters into Partnership with University College London | 25 | 1 |
| Santen Pharma to Enter into Agreement with University College London | 26 | 1 |
| Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies | 27 | 2 |
| Teva Pharma Partners with University College London and Imanova | 29 | 1 |
| University College London Enters into Research Agreement with Takeda Pharma | 30 | 1 |
| Magnus Life Science Partners with University College London | 31 | 1 |
| UCL Business Forms Joint Venture with Syncona | 32 | 1 |
| Cell Therapy Catapult Forms Catapult Therapy TCR with UCL Business and Imperial Innovations | 33 | 2 |
| Takeda Enters into R&D Agreement with University College London | 35 | 1 |
| iQur Enters into Co-Development Agreement with Six Consortium | 36 | 2 |
| Almac Enters Into Co-Development Agreement With University College London For Metagenomics, Enzyme Discovery Tools | 38 | 1 |
| Cellectis Enters Into Co-Development Agreement With University College London | 39 | 1 |
| Eisai Enters Into Drug Discovery Agreement With University College London For Neurological Drugs | 40 | 1 |
| Sarepta Therapeutics Enters Into Co-Development Agreement With University College London | 41 | 1 |
| Horizon Discovery Enters Into R&D Agreement With UCL Institute of Neurology For rAAV-mediated Genome Editing | 42 | 1 |
| TAP Biosystems Enters Into Co-Development Agreement With University College London | 43 | 2 |
| Cancer Research Technology Enters Into Co-Development Agreement With ADC Therapeutics For Antibody Drug Conjugates | 45 | 2 |
| Medical Research Council, Imperial College, King's College and UCL Form Joint Venture | 47 | 1 |
| UCL Ear Institute And UCL Business Enter Into Co-Developemnt Agreement With Autifony Therapeutics | 48 | 1 |
| UCL Business And National Centre for Young People Enters Into Commercialization Agreement With Special Products For Epistatus | 49 | 1 |
| Eisai Enters Into Research Agreement With University College London | 50 | 1 |
| Imperial College London, King's College London, University College London, Medical Research Council And GSK Form Joint Venture | 51 | 2 |
| PolyTherics Enters Into Collaboration With University College London | 53 | 1 |
| AstraZeneca Enters Agreement With UCL Business To Develop Regenerative Medicines For Diabetic Retinopathy | 54 | 2 |
| AstraZeneca Enters Into Co-Development Agreement With University College London | 56 | 1 |
| Licensing Agreements | 57 | 1 |
| Autolus Enters into Licensing Agreement with UCL Business | 57 | 1 |
| Antitope Enters into Licensing Agreement with University College London for Humanized Antibodies | 58 | 1 |
| Oxford Pharmascience Extends Licensing Agreement With UCL Business | 59 | 1 |
| BioMarin Pharma Enters Into Licensing Agreement With University College London And St. Jude Children's Research Hospital For Hemophilia A Gene Therapy Program | 60 | 2 |
| Oxford Pharmascience Enters Into Licensing Agreement With UCL Business For Drug Delivery Technology | 62 | 1 |
| University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology | 63 | 1 |
| UCL Business Enters Into Licensing Agreement With Periowave Dental Technologies | 64 | 1 |
| AbD Serotec Enters Into An Agreement With UCL Business | 65 | 1 |
| University College London - Key Competitors | 66 | 1 |
| Key Employees | 67 | 1 |
| Locations And Subsidiaries | 68 | 2 |
| Head Office | 68 | 1 |
| Other Locations &Subsidiaries | 68 | 2 |
| Appendix | 70 | 1 |
| Methodology | 70 | 1 |
| About GlobalData | 70 | 1 |
| Contact Us | 70 | 1 |
| Disclaimer | 70 | 1 |